| | | Single nucleotide variant (nonsense) | Breast cancer, susceptibility to | |
| | HMMR, HMMR-AS1 (V556A +3 more) | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to +1 more | |
| | | Deletion (frameshift variant) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +2 more) | Familial cancer of breast +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Ataxia-telangiectasia syndrome +3 more | |
| | | Single nucleotide variant (splice acceptor variant +1 more) | Breast cancer, susceptibility to +3 more | |
| | | Single nucleotide variant (nonsense +1 more) | Breast cancer, susceptibility to +3 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to +1 more | |
| | | Duplication (frameshift variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (missense variant) | Breast cancer, susceptibility to +1 more | |
| | | Duplication (frameshift variant) | Breast cancer, susceptibility to | |
| | | Duplication (intron variant +1 more) | Breast cancer, susceptibility to | |
| | | Indel (missense variant +1 more) | Breast cancer, susceptibility to +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast cancer, susceptibility to +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant) | not provided +2 more | |
| | | Duplication (nonsense +2 more) | Familial cancer of breast +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant) | Familial cancer of breast +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 2 +4 more | |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +4 more | |
| | | Single nucleotide variant (splice donor variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 2 | |
| | | Single nucleotide variant (nonsense) | Ataxia-telangiectasia syndrome +4 more | |
| | | Microsatellite (inframe_deletion) | PTEN hamartoma tumor syndrome +2 more | |
| | | Single nucleotide variant (missense variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | BRCA1, LOC126862571 (T1119S +20 more) | Single nucleotide variant (missense variant +1 more) | Hereditary breast ovarian cancer syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant +1 more) | Ataxia-telangiectasia syndrome +4 more | |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice acceptor variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Breast cancer, susceptibility to +4 more | GPathogenic/Likely pathogenic |
| | | Microsatellite (splice donor variant +1 more) | not provided +5 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Breast cancer, susceptibility to +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (splice donor variant) | Breast cancer, susceptibility to +8 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Nijmegen breakage syndrome-like disorder +2 more | |
| | | Single nucleotide variant (nonsense) | PALB2-related disorder +5 more | |
| | | Deletion (frameshift variant) | Hereditary cancer-predisposing syndrome +5 more | |
| | | Deletion (frameshift variant +1 more) | Ataxia-telangiectasia syndrome +4 more | |
| | | Deletion (frameshift variant) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Familial cancer of breast +4 more | |
| | | Single nucleotide variant (nonsense +2 more) | Breast cancer, susceptibility to +3 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense +1 more) | Breast cancer, susceptibility to +5 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Familial cancer of breast +4 more | |
| | | Single nucleotide variant (splice donor variant) | Li-Fraumeni syndrome 2 +11 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Li-Fraumeni syndrome 2 +14 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Breast and colorectal cancer, susceptibility to +20 more | |
| | | Single nucleotide variant (missense variant) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | Breast cancer, susceptibility to +6 more | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +4 more | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 1 +11 more | |
| | | Deletion (frameshift variant) | Familial cancer of breast +6 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Deletion (frameshift variant) | Familial cancer of breast | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (intron variant) | not provided | |
| | | Single nucleotide variant (3 prime UTR variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (intron variant) | Breast cancer, susceptibility to | |
| | | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | | Single nucleotide variant (missense variant) | CHEK2-related disorder +12 more | GPathogenic/Likely pathogenic/Pathogenic, low penetrance/Established risk allele |
| | | Single nucleotide variant (missense variant) | Familial cancer of breast | |
| | | Indel (frameshift variant) | Familial cancer of breast | |
| | | Single nucleotide variant (missense variant +1 more) | Familial cancer of breast | |
| | CYP17A1, CYP17A1-AS1 (R239*) | Single nucleotide variant (nonsense) | Deficiency of steroid 17-alpha-monooxygenase +1 more | |
| | | Single nucleotide variant (nonsense) | Familial cancer of breast +2 more | |
| | | Single nucleotide variant (nonsense) | not provided +4 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant) | not provided +7 more | GConflicting classifications of pathogenicity; association; risk factor |